Evidence map›Paper›PMID 37111795›Full record

ReviewPharmaceutics2023

Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications.

Nimeet Desai, Dhwani Rana, Sagar Salave, Raghav Gupta, Pranav Patel, Bharathi Karunakaran, Amit Sharma, Jyotsnendu Giri, Derajram Benival, Nagavendra Kommineni

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 2 pooled it
58.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 2 syntheses or guidelines pooled it, 518 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Pickering Emulsion Stabilized by Chitosan-ModifiedPharmaceuticals (Basel, Switzerland) · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nimeet DesaiDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi 502285, India.ORCID 0000-0002-3575-6671
Dhwani RanaNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.
Sagar SalaveNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.ORCID 0000-0003-3000-1998
Raghav GuptaNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.
Pranav PatelNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.
Bharathi KarunakaranNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.
Amit SharmaNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.ORCID 0000-0003-1060-007X
Jyotsnendu GiriDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi 502285, India.
Derajram BenivalNational Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.
Nagavendra KommineniCenter for Biomedical Research, Population Council, New York, NY 10065, USA.ORCID 0000-0003-4771-7925
National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad · INIndian Institute of Technology Hyderabad · INPopulation Council · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan, a biocompatible and biodegradable polysaccharide derived from chitin, has surfaced as a material of promise for drug delivery and biomedical applications. Different chitin and chitosan extraction techniques can produce materials with unique properties, which can be further modified to enhance their bioactivities. Chitosan-based drug delivery systems have been developed for various routes of administration, including oral, ophthalmic, transdermal, nasal, and vaginal, allowing for targeted and sustained release of drugs. Additionally, chitosan has been used in numerous biomedical applications, such as bone regeneration, cartilage tissue regeneration, cardiac tissue regeneration, corneal regeneration, periodontal tissue regeneration, and wound healing. Moreover, chitosan has also been utilized in gene delivery, bioimaging, vaccination, and cosmeceutical applications. Modified chitosan derivatives have been developed to improve their biocompatibility and enhance their properties, resulting in innovative materials with promising potentials in various biomedical applications. This article summarizes the recent findings on chitosan and its application in drug delivery and biomedical science.

Indexed as

chitinchitosandrug deliverytissue regenerationwound healing

Identifiers

PMID37111795
PMCPMC10144389
OpenAlexW4366684918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.